
Global Healthcare Contract Development & Manufacturing Organization Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
16729
May 2023
188
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
“Global Healthcare Contract Development & Manufacturing Organization Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global healthcare contract development & manufacturing organization market has been segmented on the basis of service, as well as regions and countries.
Overview:
A Contract Manufacturing Organization (CMO), also known as contract development and manufacturing organizations (CDMOs), are companies that provide services in the healthcare industry on a contractual basis.
Dynamics:
The steady increase in outsourcing of research & development is one of many major factors that is expected to significantly influence the revenue growth of the global contract development & manufacturing organization market. In order to satiate the demand for biologics and small molecules in emerging economies, a majority of biopharmaceutical and pharmaceutical companies opt to outsource their manufacturing activities. Additionally, favorable regulatory affairs as well as the guarantee of quality services are other major factors that are immensely contributing to future market growth of the CDMO industry.
However, the threat of infringement of Intellectual Property (IP) rights, rising logistic costs and serialization issues faced by healthcare companies are some of the factors that may restrain revenue growth of the global contract development & manufacturing organization market in the foreseeable future.
Segmentation of the global contract development & manufacturing organization market is as follows:
In terms of services, the contract manufacturing segment accounted for the majority revenue share of the global contract development & manufacturing organization market in 2019, and is projected to expand at the fastest rate of revenue growth over the next 10 years, owing to the complexity of manufacturing devices, the increasing adoption of outsourcing practices, as well as the rising use of medical devices as a result of a surge in the incidence of chronic diseases.
Regional Segmentation and Analysis:
North America accounted for the majority revenue share of the global contract development & manufacturing organization market in 2019, and is expected to continue to do so in the years to come. This can be accredited to an increase in the prevalence of chronic diseases due to a change in lifestyle habits such as lack of physical activity, smoking, excessive drinking of alcohol, etc. The APAC region is expected to register the fastest rate of revenue growth in the near future, due to low manufacturing costs when compared to countries in Europe and North America.
Segmentation of the Global Healthcare Contract Development & Manufacturing Organization Market:
Segmentation by Service:
- Contract Development
- Preclinical
- Bioanalysis and DMPK studies
- Toxicology Testing
- Other Preclinical Services
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Laboratory Services
- Bioanalytical Services
- Analytical Services
- Contract Development
- API/Bulk Drugs
- Finished Dose Formulations
- Medical Device
- Class I
- Class II
- Class III
Segmentation by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Catalent Inc.
- Lonza Group Ltd.
- Recipharm AB
- Siegfried Holding AG
- Thermo-Fisher Scientific Inc.
- Covance Inc.
- Jabil
- Sanmina Corporation
- IQVIA Holdings Inc.
- Flex
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!